Moderna stock reversed lower Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.
Pfizer stock is now above its 50-day line on better-than-expected first-quarter sales. Is PFE stock a buy now?
The FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.